An announcement from Bio-Gene Technology Ltd. ( (AU:BGT) ) is now available.
Bio-Gene Technology Ltd has announced the launch of a Share Purchase Plan (SPP) following a successful $2.1 million share placement to sophisticated and professional investors. The SPP allows eligible shareholders to purchase up to $15,000 in shares with free-attaching options, without brokerage fees. The funds raised will support regulatory studies for Flavocide, preparations for Qcide scale-up, and other strategic projects. This initiative aims to strengthen Bio-Gene’s market position and support its growth and development activities.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Ltd is an Australian company focused on developing new insecticides derived from natural sources. The company aims to create high-impact solutions for global markets, with a particular emphasis on regulatory studies and product scale-up for its key products, Flavocide and Qcide.
Average Trading Volume: 181,697
Technical Sentiment Signal: Sell
Current Market Cap: A$4.63M
For an in-depth examination of BGT stock, go to TipRanks’ Stock Analysis page.